Bogle Investment Management’s Edwards Lifesciences EW Stock Holding History

Bogle Investment Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-259,191	Closed	-$12.6M	–	286
2018 Q2	$12.6M	Sell	259,191 -26,958	-9%	-$1.26M	0.91%	40
2018 Q1	$13.3M	Buy	+286,149	New	+$12.4M	1%	19
2017 Q3	–	Sell	-250,767	Closed	-$9.88M	–	308
2017 Q2	$9.88M	Buy	250,767 +202,167	+416%	+$7.38M	0.72%	64
2017 Q1	$1.52M	Buy	+48,600	New	+$1.52M	0.11%	170
2016 Q3	–	Sell	-369,231	Closed	-$12.3M	–	379
2016 Q2	$12.3M	Sell	369,231 -69,669	-16%	-$2.38M	0.85%	31
2016 Q1	$12.9M	Buy	+438,900	New	+$12.1M	0.86%	30
2015 Q2	–	Sell	-745,872	Closed	-$17.7M	–	378
2015 Q1	$17.7M	Sell	745,872 -8,664	-1%	-$194K	1.22%	8
2014 Q4	$16M	Sell	754,536 -294	-0%	-$5.91K	1.06%	8
2014 Q3	$12.8M	Buy	754,830 +17,400	+2%	+$275K	0.83%	33
2014 Q2	$10.6M	Buy	+737,430	New	+$10M	0.71%	59

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bogle Investment Management's EW Position: Q3 2018 in Review

Bogle Investment Management sold out of Edwards Lifesciences (EW) in Q3 2018, closing a stake of 259,191 shares — an estimated $12.6M sold.

Bogle Investment Management first reported a position in EW in Q2 2014 and held it in 10 quarters. The position peaked at $17.7M in Q1 2015. 852 funds tracked by Wall St. Rank hold EW as of Q3 2018.

Bogle Investment Management reported no remaining Edwards Lifesciences position as of Q3 2018 after selling out during the quarter.
Bogle Investment Management sold 259,191 Edwards Lifesciences shares in Q3 2018, an estimated $12.6M.
Bogle Investment Management first reported a position in Edwards Lifesciences in Q2 2014 and held it in 10 quarters.
Bogle Investment Management's Edwards Lifesciences position peaked at $17.7M in Q1 2015.
852 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2018.

Based on Bogle Investment Management's 13F filing for Q3 2018, filed 13 Nov 2018.